APA (7th ed.) Citation

G, D. S., F, B., C, G., A, I., G, B., F, C., . . . AF, M. (2020). Long-term correction of ornithine transcarbamylase deficiency in Spf-Ash mice with a translationally optimized AAV vector. Molecular therapy. Methods & clinical development, 20, 169. https://doi.org/10.1016/j.omtm.2020.11.005

Chicago Style (17th ed.) Citation

G, De Sabbata, et al. "Long-term Correction of Ornithine Transcarbamylase Deficiency in Spf-Ash Mice with a Translationally Optimized AAV Vector." Molecular Therapy. Methods & Clinical Development 20 (2020): 169. https://doi.org/10.1016/j.omtm.2020.11.005.

MLA (9th ed.) Citation

G, De Sabbata, et al. "Long-term Correction of Ornithine Transcarbamylase Deficiency in Spf-Ash Mice with a Translationally Optimized AAV Vector." Molecular Therapy. Methods & Clinical Development, vol. 20, 2020, p. 169, https://doi.org/10.1016/j.omtm.2020.11.005.